An aqueous formulation of recombinant human FSH is more efficient than a freeze-dried cake formulation in clomiphene-resistant women with chronic anovulation

Today's Therapeutic Trends

Volumn 22, Issue 3, 2004, Pages 147-165

  Garcia, Jairo E ^a   Kettel, L Michael ^b   Klein, Nancy A ^c   Odem, Randall R ^d   Penzias, Alan S ^e   Silverberg, Kaylen M ^f   Steinkampf, Michael P ^g   Young, James E ^h   Young, Philip ⁱ   Mahony, Mary ^j  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Male Fertility Specialists in San Diego   (United States)

^c Zarutskie Fertility and Endocrine Institute   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON IVF   (United States)

^f Texas Fertility Center   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h Michigan Reproductive and IVF Center   (United States)

ⁱ San Diego Medical Center   (United States)

^j Organon Pharmaceuticals USA Inc   (United States)

more..

Author keywords

Drug tolerance; FSH; Infertility; Ovulation induction

Indexed keywords

EID: 5044221912     PISSN: 07412320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Howies CM: Role of LH and FSH in ovarian function. Mol. Cell. Endocrinol. 161:25-30, 2000.
2. Harlin J, Csemiczky G, Wramsby H and Fried G: Recombinant follicle stimulating hormone in in-vitro fertilization treatment-Clinical experience with follitropin alpha and follitropin beta. Hum. Reprod. 75:239-244, 2000. (Pubitemid 30076700)
3. Out HJ, Mannaerts B M JL, Driessen S G AJ and Coelingh Bennink H J T: A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.. Hum. Reprod. 70:2534-2540, 1995.
4. ®) in a fixed-dose regimen in women undergoing ovarian stimulation.. Hum. Reprod. 24:2442-2447, 1999.
5. Daya S: Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction.. Fertil. Steril. 77:711-714, 2002. (Pubitemid 34275349)
6. Coelingh Bennink H J T, Fauser B C JM and Out HJ, for the European Puregon Collaborative Anovulation Study Group: Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women, with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: A prospective, multicenter, assessor-blind, randomized, clinical trial. Fertil. Steril. 69:19-25, 1998. (Pubitemid 28072985)
7. Out HJ, Reimitz PE and Coelingh Bennink H J T: A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon).. Fertil. Steril. 67:278-283, 1997. (Pubitemid 27052185)
8. Mantel N and Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22:719-748, 1959.
9. van Elteren PH: On the combination of independent two sample tests of Wilcoxon. Bull. Int. Stat. Inst. 57:351-361, 1960.
10. Prevost RR: Recombinant follicle-stimulating hormone: New biotechnology for infertility. Pharmacotherapy 75:1001-1010, 1998. (Pubitemid 28439986)
11. Out HJ, Mannaerts B M JL, Driessen S G AJ and Coelingh Bennink H J T: Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: More oocytes, more pregnancies. Results from five comparative studies. Hum. Reprod. Update 2:162-171, 1996. (Pubitemid 26173042)
12. ® (follitropin beta) prescribing information. Organon Inc., West Orange, NJ.
13. Voortman G, Mannaerts B M JL and Huisman J A M: A dose proportionality study of subcutaneously and intramuscularly administered recombinant human folliclestimulating hormone (Follistim/Puregon) in healthy female volunteers.. Fertil. Steril. 75:1187-1193, 2000. (Pubitemid 30336767)
14. Kamrava MM, Seibel MM, Berger MJ, et al.: Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic low-dose folliclestimulating hormone.. Fertil. Steril. 57:520-523, 1982. (Pubitemid 12141836)
15. White DM, Poison DW, Kiddy D, et al.: Extensive personal experience: Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: An analysis of 109 pregnancies in 225 women.. J. Clin. Endocrinol. Metab. 57:3821-3824, 1996. (Pubitemid 26380380)
16. Fauser B C JM and van Heusden AM: Manipulation of human ovarian function: Physiological concepts and clinical consequences. Endocr. Rev. 75:71-105, 1997.
17. Hayden CJ, Ruterford AJ and Balen AH: Induction of ovulation with the use of a starting dose of 50 units of recombinant human follicle-stimulating hormone (Puregon).. Fertil. Steril. 77:106-108, 1999. (Pubitemid 29042352)
18. Christin-Maitre S and Hugues JN, on behalf of the Recombinant FSH Study Group: A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome.. Hum. Reprod. 18:1626-1631, 2003. (Pubitemid 36958040)